NIH-funded research R01 grant

Understanding how branched chain amino acids affect diabetes and metabolism

Official title: Covalent regulation of branched chain amino acid metabolism

Funded at Washington University · NIH-11072074 · Data updated 2026-11-12

This study is looking at how certain amino acids, called branched chain amino acids (BCAAs), might affect the development of type 2 diabetes and insulin resistance, especially in people who are overweight, to find new ways to help manage diabetes through diet and treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startApril 15, 2024
Project endFebruary 29, 2028
Funding year2025
Award (this year)$461,782
NIH project number5R01DK136749-02
Project IDNIH-11072074 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults with obesity or insulin resistance, particularly those at risk for developing type 2 diabetes.

Less likely to help

Patients who do not have issues related to obesity or insulin resistance may not benefit from this research.

What this research studies

This research investigates the role of branched chain amino acids (BCAAs) in the development of type 2 diabetes and insulin resistance. It explores how high levels of BCAAs, often seen in individuals with obesity, may contribute to metabolic dysfunction. The study aims to identify the mechanisms by which BCAAs are metabolized and regulated in the body, potentially leading to new dietary or therapeutic strategies to improve insulin sensitivity and manage diabetes. By examining genetic variations and dietary impacts on BCAA levels, the research seeks to uncover novel approaches to diabetes treatment.

Why it matters

Potential benefit: If successful, this research could lead to new dietary guidelines or therapies that help manage or prevent type 2 diabetes by targeting amino acid metabolism.

How similar studies have gone: Previous research has shown promising results in managing insulin sensitivity through dietary modifications related to amino acid metabolism, indicating that this approach has potential for success.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Finck, Brian N — Washington University
  • Study coordinator: Finck, Brian N

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.